Related references
Note: Only part of the references are listed.Behavioral, neuroanatomical, and molecular correlates of resilience and susceptibility to maternal immune activation
Flavia S. Mueller et al.
MOLECULAR PSYCHIATRY (2021)
Preclinical validation of the micropipette-guided drug administration (MDA) method in the maternal immune activation model of neurodevelopmental disorders
Joseph Scarborough et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Dependency of prepulse inhibition deficits on baseline startle reactivity in a mouse model of the human 22q11.2 microdeletion syndrome
Joseph Scarborough et al.
GENES BRAIN AND BEHAVIOR (2019)
Maternal immune activation: reporting guidelines to improve the rigor, reproducibility, and transparency of the model
Amanda C. Kentner et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Influence of poly(I:C) variability on thermoregulation, immune responses and pregnancy outcomes in mouse models of maternal immune activation
Flavia S. Mueller et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities
Amanda Krogmann et al.
CNS SPECTRUMS (2019)
Challenges and opportunities of a-priori and a-posteriori variability in maternal immune activation models
Ulrike Weber-Stadlbauer et al.
CURRENT OPINION IN BEHAVIORAL SCIENCES (2019)
Prevention of Relapse in Schizophrenia: A Phase II Study Evaluating Efficacy, Safety, and Tolerability of Oral BI 409306
Michael Sand et al.
BIOLOGICAL PSYCHIATRY (2018)
Maternal Immune Activation and Neuropsychiatric Illness: A Translational Research Perspective
Alan S. Brown et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
A Phase IC Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Cognitive Outcomes of BI 409306 in Patients with Mild-to-Moderate Schizophrenia
David Brown et al.
NEUROLOGY AND THERAPY (2018)
Transgenerational transmission and modification of pathological traits induced by prenatal immune activation
U. Weber-Stadlbauer et al.
MOLECULAR PSYCHIATRY (2017)
A phase I, randomized, proof-of-clinical-mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral PDE9A inhibitor BI 409306 in healthy male volunteers
Katja Boland et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2017)
M15. Early Intervention in Attenuated Psychosis Syndrome: A Phase II Study Evaluating Efficacy, Safety, and Tolerability of Oral BI 409306
Richard Keefe et al.
SCHIZOPHRENIA BULLETIN (2017)
Effects of Immune Activation during Early or Late Gestation on N-Methyl-D-Aspartate Receptor Measures in Adult Rat Offspring
Tasnim Rahman et al.
FRONTIERS IN PSYCHIATRY (2017)
GABAergic Function as a Limiting Factor for Prefrontal Maturation during Adolescence
Adriana Caballero et al.
TRENDS IN NEUROSCIENCES (2016)
Behavioral Effects of the Benzodiazepine-Positive Allosteric Modulator SH-053-2'F-S-CH3 in an Immune-Mediated Neurodevelopmental Disruption Model
Juliet Richetto et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia
Andrew J. Pocklington et al.
NEURON (2015)
Converging models of schizophrenia - Network alterations of prefrontal cortex underlying cognitive impairments
Takeshi Sakurai et al.
PROGRESS IN NEUROBIOLOGY (2015)
The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia
Samuel M. Cohen et al.
SCHIZOPHRENIA RESEARCH (2015)
Schizophrenia: a tale of two critical periods for prefrontal cortical development
L. D. Selemon et al.
TRANSLATIONAL PSYCHIATRY (2015)
The neurobiology and treatment of first-episode schizophrenia
R. S. Kahn et al.
MOLECULAR PSYCHIATRY (2015)
Neurodevelopment, GABA System Dysfunction, and Schizophrenia
Martin J. Schmidt et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Prenatal Poly(I:C) Exposure and Other Developmental Immune Activation Models in Rodent Systems
Urs Meyer
BIOLOGICAL PSYCHIATRY (2014)
Prenatal Immune Activation Induces Maturation-Dependent Alterations in the Prefrontal GABAergic Transcriptome
Juliet Richetto et al.
SCHIZOPHRENIA BULLETIN (2014)
To poly(I:C) or not to poly(I:C): Advancing preclinical schizophrenia research through the use of prenatal immune activation models
Urs Meyer et al.
NEUROPHARMACOLOGY (2012)
Glutamate signaling in the pathophysiology and therapy of schizophrenia
Chieh-Hsin Lin et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring
Caroline M. Forrest et al.
MOLECULAR BRAIN (2012)
Phosphodiesterase 9A Regulates Central cGMP and Modulates Responses to Cholinergic and Monoaminergic Perturbation In Vivo
Robin J. Kleiman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801
Nicole L. Roenkerd et al.
NEUROSCIENCE LETTERS (2011)
A Longitudinal Examination of the Neurodevelopmental Impact of Prenatal Immune Activation in Mice Reveals Primary Defects in Dopaminergic Development Relevant to Schizophrenia
Stephanie Vuillermot et al.
JOURNAL OF NEUROSCIENCE (2010)
Late Prenatal Immune Activation in Mice Leads to Behavioral and Neurochemical Abnormalities Relevant to the Negative Symptoms of Schizophrenia
Byron K. Y. Bitanihirwe et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Evaluating Early Preventive Antipsychotic and Antidepressant Drug Treatment in an Infection-Based Neurodevelopmental Mouse Model of Schizophrenia
Urs Meyer et al.
SCHIZOPHRENIA BULLETIN (2010)
Selective phosphodiesterase inhibitors: a promising target for cognition enhancement
Olga A. H. Reneerkens et al.
PSYCHOPHARMACOLOGY (2009)
Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice
Urs Meyer et al.
BRAIN BEHAVIOR AND IMMUNITY (2008)
Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge
Urs Meyer et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: A neurodevelopmental animal model of schizophrenia
K Ozawa et al.
BIOLOGICAL PSYCHIATRY (2006)
Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring
L Zuckerman et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2005)
Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia
U Meyer et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: A novel neurodevelopmental model of schizophrenia
L Zuckerman et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?
AM Ouagazzal et al.
PSYCHOPHARMACOLOGY (2001)
Share Paper
